Apogee Therapeutics (APGE) Total Current Liabilities (2022 - 2026)
Apogee Therapeutics (APGE) posted quarterly Total Current Liabilities of $33.0 million for Q1 2026, little changed year-over-year from $33.0 million in Q1 2025, and up 18.08% quarter-over-quarter from $27.9 million in Q4 2025.
Apogee Therapeutics (APGE) Total Current Liabilities (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has reported Total Current Liabilities for 5 consecutive years, with $33.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities changed 0.02% year-over-year to $33.0 million; the TTM figure through Mar 2026 stood at $33.0 million (changed 0.02% YoY), while the FY2025 annual figure was $27.9 million, down 2.29% from the prior year.
- Total Current Liabilities improved to $33.0 million in Q1 2026 per APGE's latest filing, from $27.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $34.0 million in Q3 2025 and bottomed at $10.0 million in Q4 2022.
- Historically, Total Current Liabilities has averaged $25.5 million across 5 years, with a median of $27.9 million in 2025.
- Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 105.99% — and 2025, when it retreated 2.29%.
- Apogee Therapeutics' Total Current Liabilities stood at $10.0 million in 2022, then surged by 105.99% to $20.6 million in 2023, then soared by 38.92% to $28.6 million in 2024, then decreased by 2.29% to $27.9 million in 2025, then climbed by 18.08% to $33.0 million in 2026.
- Business Quant data shows APGE's Total Current Liabilities at $33.0 million in Q1 2026, $27.9 million in Q4 2025, and $34.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Apogee Therapeutics | 10.14 Bn | 9.16 Bn | - | 37.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.51 Mn |
| Mar 31, 2026 | 32.95 Mn |
| Dec 31, 2025 | 27.91 Mn |
| Sep 30, 2025 | 34.05 Mn |
| Jun 30, 2025 | 31.55 Mn |
| Mar 31, 2025 | 32.96 Mn |
| Dec 31, 2024 | 28.56 Mn |
| Sep 30, 2024 | 32.61 Mn |
| Jun 30, 2024 | 24.62 Mn |
| Mar 31, 2024 | 21.55 Mn |
| Dec 31, 2023 | 20.56 Mn |
| Sep 30, 2023 | 17.18 Mn |
| Jun 30, 2023 | 17.62 Mn |
| Dec 31, 2022 | 9.98 Mn |